Tirzepatide emerges a groundbreaking therapeutic agent for individuals battling type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://elainezkfu572097.qowap.com/99583255/tirzepatide-a-new-frontier-in-diabetes-treatment